Search results
Cartesian data add to progress, questions for CAR-T in autoimmune disease
BioPharma Dive· 5 days agoThe company claimed Phase 2 study results prove the therapy’s promise treating myasthenia gravis....
HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
Clinical Trials Arena· 5 days agoLast year, HOOKIPA dosed the first patient in a Phase I trial of HB-400, a non-replicating...
Eisai and Bristol Myers Squibb terminate ADC development deal
Pharmaceutical Technology· 5 days agoThe asset is being analysed in three clinical trials: Eisai's Phase I/II trial for solid tumours,...
NIH announces start of subject enrolment for nasal Covid-19 vaccine trial
Clinical Trials Arena· 5 days agoThe US National Institutes of Health (NIH) has announced the start of subject enrolment for a Phase ...
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena· 5 days agoBoehringer Ingelheim and Gubra have initiated a Phase I clinical trial of BI 3034701, a long-acting...
Samsung Bioepis’ PYZCHIVA gains FDA approval as Stelara biosimilar
Pharmaceutical Technology· 5 days agoThe approval is based on comprehensive evidence confirming its biosimilarity to Stelara. This...
Translational research: Out of the lab, into the clinic
Pharmaceutical Technology· 5 days agoTurning a research project into results that can directly benefit people is complex, time consuming,...
Sponsors must take on FDA’s diversity guidance to improve community trust
Medical Device Network· 5 days agoWith data still showing that ethnic minorities account for less than 40% of US trial populations,...
Developing a new biologic drug: regulatory challenges and considerations
Pharmaceutical Technology· 5 days agoThe journey from research lab to market is a long one, and most drug candidates do not make it. For...
Sirnaomics concludes Phase I trial of pancreatic cancer treatment
Clinical Trials Arena· 6 days agoSirnaomics has concluded the Phase I clinical trial of a small interfering RNA (siRNA) therapeutic...